vs
KKR Real Estate Finance Trust Inc.（KREF）与Xilio Therapeutics, Inc.（XLO）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是Xilio Therapeutics, Inc.的1.9倍（$25.8M vs $13.7M），Xilio Therapeutics, Inc.净利率更高（75.7% vs -101.7%，领先177.4%）
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
Xilio Therapeutics是一家临床阶段生物技术企业，专注开发用于多种癌症治疗的新型肿瘤选择性免疫疗法，其在研候选药物可在肿瘤微环境中特异性激活抗肿瘤免疫反应，降低全身性毒副作用，主要面向北美及全球其他地区的肿瘤患者群体。
KREF vs XLO — 直观对比
营收规模更大
KREF
是对方的1.9倍
$13.7M
净利率更高
XLO
高出177.4%
-101.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $13.7M |
| 净利润 | $-26.2M | $10.4M |
| 毛利率 | — | — |
| 营业利润率 | -105.1% | -86.5% |
| 净利率 | -101.7% | 75.7% |
| 营收同比 | -26.6% | — |
| 净利润同比 | -229.6% | 179.1% |
| 每股收益（稀释后） | $-0.49 | $-3.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KREFXLO
| Q4 25 | $25.8M | $13.7M | ||
| Q3 25 | $25.3M | $19.1M | ||
| Q2 25 | $30.2M | $8.1M | ||
| Q1 25 | $31.3M | $2.9M | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $37.0M | — | ||
| Q2 24 | $40.4M | — | ||
| Q1 24 | $39.1M | — |
净利润KREFXLO
| Q4 25 | $-26.2M | $10.4M | ||
| Q3 25 | $13.8M | $-16.3M | ||
| Q2 25 | $-29.7M | $-15.8M | ||
| Q1 25 | $-4.9M | $-13.3M | ||
| Q4 24 | $20.3M | — | ||
| Q3 24 | $-7.4M | — | ||
| Q2 24 | $25.8M | — | ||
| Q1 24 | $-3.1M | — |
营业利润率KREFXLO
| Q4 25 | -105.1% | -86.5% | ||
| Q3 25 | 50.4% | -10.1% | ||
| Q2 25 | -101.3% | -177.7% | ||
| Q1 25 | -18.3% | -472.7% | ||
| Q4 24 | 55.8% | — | ||
| Q3 24 | -19.6% | — | ||
| Q2 24 | 63.3% | — | ||
| Q1 24 | -8.7% | — |
净利率KREFXLO
| Q4 25 | -101.7% | 75.7% | ||
| Q3 25 | 54.4% | -85.4% | ||
| Q2 25 | -98.5% | -196.0% | ||
| Q1 25 | -15.5% | -452.7% | ||
| Q4 24 | 57.7% | — | ||
| Q3 24 | -20.0% | — | ||
| Q2 24 | 63.9% | — | ||
| Q1 24 | -7.9% | — |
每股收益（稀释后）KREFXLO
| Q4 25 | $-0.49 | $-3.74 | ||
| Q3 25 | $0.12 | $-0.11 | ||
| Q2 25 | $-0.53 | $-0.16 | ||
| Q1 25 | $-0.15 | $-0.18 | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $-0.19 | — | ||
| Q2 24 | $0.29 | — | ||
| Q1 24 | $-0.13 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $35.3M |
| 总资产 | $6.5B | $154.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KREFXLO
| Q4 25 | $84.6M | $137.5M | ||
| Q3 25 | $204.1M | $103.8M | ||
| Q2 25 | $107.7M | $121.6M | ||
| Q1 25 | $106.4M | $89.1M | ||
| Q4 24 | $104.9M | — | ||
| Q3 24 | $108.8M | — | ||
| Q2 24 | $107.2M | — | ||
| Q1 24 | $106.5M | — |
股东权益KREFXLO
| Q4 25 | $1.2B | $35.3M | ||
| Q3 25 | $1.2B | $-8.1M | ||
| Q2 25 | $1.2B | $7.1M | ||
| Q1 25 | $1.3B | $10.7M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
总资产KREFXLO
| Q4 25 | $6.5B | $154.7M | ||
| Q3 25 | $6.5B | $133.7M | ||
| Q2 25 | $6.8B | $133.8M | ||
| Q1 25 | $6.6B | $103.7M | ||
| Q4 24 | $6.4B | — | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.3B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.1M |
| 自由现金流率自由现金流/营收 | — | -15.3% |
| 资本支出强度资本支出/营收 | — | 0.7% |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KREFXLO
| Q4 25 | $72.3M | $-2.0M | ||
| Q3 25 | $18.5M | $-17.5M | ||
| Q2 25 | $21.1M | $-14.5M | ||
| Q1 25 | $15.9M | $29.0M | ||
| Q4 24 | $132.6M | — | ||
| Q3 24 | $49.1M | — | ||
| Q2 24 | $30.6M | — | ||
| Q1 24 | $34.5M | — |
自由现金流KREFXLO
| Q4 25 | — | $-2.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-14.9M | ||
| Q1 25 | — | $29.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率KREFXLO
| Q4 25 | — | -15.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -184.0% | ||
| Q1 25 | — | 988.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度KREFXLO
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 5.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率KREFXLO
| Q4 25 | — | -0.19× | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
